Clinical Trial Update: Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating oxaliplatin with capecitabine and concurrent radiation therapy in non-small cell lung cancer; the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Louisville | Conditions: Carcinoma, Non-Small Cell Lung | Phase 1 | Status: TERMINATED